Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer—Translational Research Results from the Prospective ProMPT trial-Reference-Cited by-同舟云学术

Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer—Translational Research Results from the Prospective ProMPT trial

Published:2021-01 Issue:1 Volume:7 Page:55-62
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Mandel Philipp C.,Huland Hartwig,Tiebel Anne,Haese Alexander,Salomon Georg,Budäus Lars,Tilki Derya,Chun Felix,Heinzer Hans,Graefen Markus,Pantel Klaus,Riethdorf Sabine,Steuber Thomas

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer;de Bono;Clin Cancer Res,2008

2. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data;Scher;Lancet Oncol,2009

3. Circulating tumor cell number as a response measure of prolonged survival for metastatic castration-resistant prostate cancer: a comparison with prostate-specific antigen across five randomized phase III clinical trials;Heller;J Clin Oncol,2017

4. Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience;Olmos;Ann Oncol,2009

5. Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival;Danila;Eur Urol,2014

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of circulating tumor cells in oligorecurrent hormone‐sensitive prostate cancer patients undergoing stereotactic body radiation therapy;The Prostate;2024-09-06

2. Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients;Cells;2024-05-03

3. Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging;Current Opinion in Urology;2024-04-05

4. Gibt es eine Indikation zur Lokaltherapie des mHSPC?;Aktuelle Urologie;2024-03-27

5. Minimally invasive cytoreductive radical prostatectomy, exploring the safety and feasibility of a single-port or multi-port robotic platform;BMC Urology;2024-03-26